tm logo
TROKENDI XR
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 13 May 2021

Last Applicant/ Owned by

1550 East Gude Drive

Rockville

MD

20850

Serial Number

85644722 filed on 06th Jun 2012

Registration Number

4498773 registered on 18th Mar 2014

in the Principal Register

Correspondent Address

Mark D. Simpson

Saul Ewing Arnstein & Lehr LLP

1500 Market Street

Centre Square West, 38th Floor

PHILADELPHIA,PA 19102-2100

Filing Basis

1. intent to use

2. use application currently

Disclaimer

"XR"

TROKENDI XR

"XR" Pharmaceutical preparations or substances for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations or substances for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders


First Use Date in General

30th Sep 2013

First Use Date in Commerce

30th Sep 2013

Mark Details


Serial Number

No 85644722

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 356969.00029

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
18th Mar 2024TEAS SECTION 8 & 9 RECEIVED
18th Mar 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
13th May 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
13th May 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
18th Nov 2020TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
11th Nov 2020POST REGISTRATION ACTION MAILED - SEC. 8 & 15
09th Nov 2020TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
09th May 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09th May 2020POST REGISTRATION ACTION MAILED - SEC. 8 & 15
18th Mar 2020TEAS SECTION 8 & 15 RECEIVED